One possibility could be that changes in caspase-3 regulation cause an increase in EAAT2 cleavage, which leads to the toxic levels of CTE-SUMO1 observed in ALS (Foran et al., 2011). Here, SLC1A2 is linked to amyotrophic lateral sclerosis.